These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34080686)

  • 61. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
    Lowe PL; Cerdan-Sanz S; Lowe NJ
    Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
    Ibrahim O; Kakar R; Bolotin D; Nodzenski M; Disphanurat W; Pace N; Becker L; West DP; Poon E; Veledar E; Alam M
    J Am Acad Dermatol; 2013 Jul; 69(1):88-95. PubMed ID: 23591103
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR
    Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Axillary hyperhidrosis: treatment with botulinum toxin A.
    Odderson IR
    Arch Phys Med Rehabil; 1998 Mar; 79(3):350-2. PubMed ID: 9523792
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
    Alvarez MA; Ruano J; Gómez FJ; Casas E; Baamonde C; Salvatierra A; Moreno JC
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e282-8. PubMed ID: 22827710
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].
    Wohlrab J; Kreft B
    Hautarzt; 2018 Oct; 69(10):857-869. PubMed ID: 30218113
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ
    J Drugs Dermatol; 2011 Sep; 10(9):1013-5. PubMed ID: 22052270
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Palmar and plantar hyperhidrosis: best practice recommendations and special considerations.
    Glaser DA; Hebert AA; Pariser DM; Solish N
    Cutis; 2007 May; 79(5 Suppl):18-28. PubMed ID: 17596097
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis.
    Swartling C; Naver H; Lindberg M
    Eur J Neurol; 2001 May; 8(3):247-52. PubMed ID: 11328333
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effective treatment of frontal hyperhidrosis with botulinum toxin A.
    Kinkelin I; Hund M; Naumann M; Hamm H
    Br J Dermatol; 2000 Oct; 143(4):824-7. PubMed ID: 11069464
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postmenopausal craniofacial hyperhidrosis treated with botulinum toxin type B.
    Cabreus P; Swartling C; Rystedt A
    J Dermatol; 2019 Oct; 46(10):874-878. PubMed ID: 31373068
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Mallin K; Charles C; Martin LK; Black L; Bryde J
    Dermatol Surg; 2005 Mar; 31(3):263-70. PubMed ID: 15841624
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapeutic effectiveness of botulinum toxin type A based on severity of palmar hyperhidrosis.
    Ito K; Yanagishita T; Ohshima Y; Tamada Y; Watanabe D
    J Dermatol; 2011 Sep; 38(9):859-63. PubMed ID: 21545498
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of axillary hyperhidrosis with botulinum toxin: a single surgeon's experience with 53 consecutive patients.
    Doft MA; Kasten JL; Ascherman JA
    Aesthetic Plast Surg; 2011 Dec; 35(6):1079-86. PubMed ID: 21559989
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.
    Nawrocki S; Cha J
    J Am Acad Dermatol; 2020 Apr; 82(4):969-979. PubMed ID: 31811879
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.
    Lakraj AA; Moghimi N; Jabbari B
    Toxins (Basel); 2013 Apr; 5(4):821-40. PubMed ID: 23612753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Management of hyperhidrosis].
    Maillard H; Lecouflet M
    Ann Dermatol Venereol; 2015 Apr; 142(4):252-61. PubMed ID: 25697587
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.
    Lueangarun S; Sermsilp C; Tempark T
    Dermatol Surg; 2018 Aug; 44(8):1094-1101. PubMed ID: 29659406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.